CN110732012A - A Chinese medicinal composition for treating hepatitis, and its preparation method - Google Patents
A Chinese medicinal composition for treating hepatitis, and its preparation method Download PDFInfo
- Publication number
- CN110732012A CN110732012A CN201911185299.1A CN201911185299A CN110732012A CN 110732012 A CN110732012 A CN 110732012A CN 201911185299 A CN201911185299 A CN 201911185299A CN 110732012 A CN110732012 A CN 110732012A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- group
- medicinal materials
- filtrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 208000006454 hepatitis Diseases 0.000 title claims abstract description 28
- 231100000283 hepatitis Toxicity 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- 239000003814 drug Substances 0.000 claims abstract description 68
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 21
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 17
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 15
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 12
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 12
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 11
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 11
- 244000038594 Phyllanthus urinaria Species 0.000 claims abstract description 11
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 10
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 10
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 10
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 10
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 10
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 10
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 10
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 10
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 10
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 10
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 10
- 241000270666 Testudines Species 0.000 claims abstract description 10
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 10
- 241001145009 Sophora alopecuroides Species 0.000 claims abstract description 9
- 235000011477 liquorice Nutrition 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 8
- 241000096270 Swertia leducii Species 0.000 claims abstract description 8
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 8
- 241000132012 Atractylodes Species 0.000 claims abstract description 7
- 235000003405 Curcuma zedoaria Nutrition 0.000 claims abstract description 7
- 240000009138 Curcuma zedoaria Species 0.000 claims abstract description 7
- 241000257303 Hymenoptera Species 0.000 claims abstract description 7
- 244000171085 Polyporus umbellatus Species 0.000 claims abstract description 7
- 235000004837 Polyporus umbellatus Nutrition 0.000 claims abstract description 7
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 claims abstract description 7
- 210000003038 endothelium Anatomy 0.000 claims abstract description 7
- 235000019509 white turmeric Nutrition 0.000 claims abstract description 7
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 6
- 241000222336 Ganoderma Species 0.000 claims abstract description 6
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 6
- 235000006533 astragalus Nutrition 0.000 claims abstract description 6
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 5
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 5
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 5
- 244000075634 Cyperus rotundus Species 0.000 claims abstract description 5
- 235000016854 Cyperus rotundus Nutrition 0.000 claims abstract description 5
- 241001489978 Eupolyphaga Species 0.000 claims abstract description 5
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 5
- 241000237502 Ostreidae Species 0.000 claims abstract 2
- 235000020636 oyster Nutrition 0.000 claims abstract 2
- 239000000463 material Substances 0.000 claims description 42
- 239000000706 filtrate Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000009835 boiling Methods 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 235000008216 herbs Nutrition 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 6
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 6
- 235000008434 ginseng Nutrition 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 230000001954 sterilising effect Effects 0.000 claims description 5
- 241000717739 Boswellia sacra Species 0.000 claims description 3
- 241001251068 Formica fusca Species 0.000 claims description 3
- 240000008397 Ganoderma lucidum Species 0.000 claims description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 3
- 239000009636 Huang Qi Substances 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 241000180649 Panax notoginseng Species 0.000 claims description 3
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 3
- 241000222640 Polyporus Species 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 238000002791 soaking Methods 0.000 claims description 2
- 244000118681 Iresine herbstii Species 0.000 claims 1
- 240000006322 Sambucus chinensis Species 0.000 claims 1
- 235000010426 Sambucus chinensis Nutrition 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 description 29
- 230000000694 effects Effects 0.000 description 19
- 229940107666 astragalus root Drugs 0.000 description 18
- 230000001737 promoting effect Effects 0.000 description 13
- 241000700721 Hepatitis B virus Species 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 210000005229 liver cell Anatomy 0.000 description 9
- 230000008929 regeneration Effects 0.000 description 9
- 238000011069 regeneration method Methods 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 206010008909 Chronic Hepatitis Diseases 0.000 description 7
- 230000005855 radiation Effects 0.000 description 7
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 6
- 108010082126 Alanine transaminase Proteins 0.000 description 6
- 108090000340 Transaminases Proteins 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 102000014898 transaminase activity proteins Human genes 0.000 description 6
- 206010000060 Abdominal distension Diseases 0.000 description 5
- 238000008050 Total Bilirubin Reagent Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 241000227129 Aconitum Species 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 241000246044 Sophora flavescens Species 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 208000002672 hepatitis B Diseases 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- 241000092665 Atractylodes macrocephala Species 0.000 description 3
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- 244000008991 Curcuma longa Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 208000006083 Hypokinesia Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 2
- 241000222684 Grifola Species 0.000 description 2
- 206010019705 Hepatic pain Diseases 0.000 description 2
- 206010050031 Muscle strain Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 241001530209 Swertia Species 0.000 description 2
- 231100000354 acute hepatitis Toxicity 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000007882 cirrhosis Effects 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 206010019847 hepatosplenomegaly Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000002147 killing effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000173529 Aconitum napellus Species 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000132011 Atractylodes lancea Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 241000131329 Carabidae Species 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 241000007126 Codonopsis pilosula Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 235000003398 Curcuma aromatica Nutrition 0.000 description 1
- 241000234653 Cyperus Species 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 206010016326 Feeling cold Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 1
- 235000003332 Ilex aquifolium Nutrition 0.000 description 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 description 1
- 235000002294 Ilex volkensiana Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 241001243666 Photinia serratifolia Species 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 240000001341 Reynoutria japonica Species 0.000 description 1
- 235000018167 Reynoutria japonica Nutrition 0.000 description 1
- 241000767840 Semiaquilegia Species 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940023019 aconite Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- SKOLRLSBMUGVOY-GBJTYRQASA-N aloperine Chemical compound C1=C2CCCN[C@H]2[C@H]2CN3CCCC[C@@H]3[C@@H]1C2 SKOLRLSBMUGVOY-GBJTYRQASA-N 0.000 description 1
- PCTYDEAPIWWHMV-UHFFFAOYSA-N aloperine Natural products C1CCN2CC3CC(CC4CCCNC34)C2C1 PCTYDEAPIWWHMV-UHFFFAOYSA-N 0.000 description 1
- 239000003319 ant venom Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- -1 flavonoid compounds Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 208000018191 liver inflammation Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000000936 membranestabilizing effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000324 neuroprotective effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Virology (AREA)
- Insects & Arthropods (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Marine Sciences & Fisheries (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to the field of traditional Chinese medicine, in particular to traditional Chinese medicine compositions for treating hepatitis and a preparation method thereof, the traditional Chinese medicine compositions comprise, by weight, 10-100 parts of black ants, 10-100 parts of swertia mileensis, 10-100 parts of phyllanthus urinaria, 10-100 parts of lucid ganoderma, 10-100 parts of radix sophorae flavescentis, 10-100 parts of sophora alopecuroides, 10-100 parts of polyporus umbellatus, 10-100 parts of liquorice, 10-100 parts of fructus trichosanthis, 10-100 parts of red ginseng, 10-100 parts of astragalus membranaceus, 10-100 parts of radix curcumae, 10-100 parts of curcuma longa, 10-100 parts of turtle shell, 10-100 parts of rhizoma sarcandrae chinensis, 10-100 parts of curcuma zedoary, 10-100 parts of frankincense, 10-100 parts of myrrh, 10-100 parts of pseudo-ginseng, 10-100 parts of bighead atractylodes rhizome, 10-100 parts of endothelium corneum gigeriae galli, 10-100 parts of hawthorn, 10-100 parts of cyperus rotundus, 10-100 parts of radix bupleuri, 10-100 parts of oyster and 10-100 parts of eupolyphaga.
Description
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to traditional Chinese medicine compositions for treating hepatitis and a preparation method thereof.
Background
Hepatitis is a general term for liver inflammation, and generally refers to liver cell destruction caused by various pathogenic factors, such as viruses, bacteria, parasites, chemicals, poisons, drugs, alcohol, autoimmune factors, etc., liver function is damaged, and series of discomfort symptoms and abnormal liver function index are caused.
The hepatitis is divided into acute hepatitis and chronic hepatitis, the acute viral hepatitis is mainly caused by hepatropic hepatitis virus A, B, C, D, E, non-specific hepatropic viruses such as cytomegalovirus, Epstein-Barr virus, herpes simplex virus and the like can also cause the hepatitis, but the hepatitis is rare, while the chronic hepatitis B (hepatitis B for short) refers to the hepatitis B virus which is detected to be positive, the disease course is more than half a year or the disease date is not clear and the clinical symptoms of chronic hepatitis are symptoms such as hypodynamia, chilliness, nausea, abdominal distension, liver pain and the like.
Although the etiology of hepatitis is different, it has similar clinical manifestations, but the etiology, serology, damage mechanism, clinical diagnosis and treatment are different.
At present, a lot of medicines for treating acute hepatitis and chronic hepatitis are used in China, and in western medicines, nucleoside antiviral medicines are often used for treating hepatitis, but the medicine has large side effect, and patients are easy to generate drug resistance, and the treatment effect is poor. However, in the traditional Chinese medicines, the traditional Chinese medicines with good treatment effect are few, and the treatment effect of combining treatment and function recovery cannot be achieved.
Disclosure of Invention
The invention aims to solve the technical problem of providing kinds of treatment effects which can fundamentally realize the combination of treatment and function recovery.
The technical scheme for solving the technical problems is that traditional Chinese medicine compositions for treating hepatitis comprise, by weight, 10-100 parts of black ants, 10-100 parts of swertia mileensis, 10-100 parts of phyllanthus urinaria, 10-100 parts of lucid ganoderma, 10-100 parts of radix sophorae flavescentis, 10-100 parts of sophora alopecuroides, 10-100 parts of polyporus umbellatus, 10-100 parts of liquorice, 10-100 parts of fructus trichosanthis, 10-100 parts of red ginseng, 10-100 parts of astragalus membranaceus, 10-100 parts of radix curcumae, 10-100 parts of curcuma longa, 10-100 parts of turtle shell, 10-100 parts of rhizoma sarcandrae chinensis, 10-100 parts of curcuma zedoary, 10-100 parts of frankincense, 10-100 parts of myrrh, 10-100 parts of pseudo-ginseng, 10-100 parts of bighead atractylodes rhizome, 10-100 parts of endothelium corneum gigeriae galli, 10-100 parts of hawthorn, 10-100 parts of cyperus rotu.
steps, which comprise (by weight parts) Formica fusca 30-80, swertia mileensis 30-80, cacumen Securinegae Suffruticosae 30-80, Ganoderma 30-80, radix Sophorae Flavescentis 30-80, herba Sophorae Alopecuroidis 30-80, Polyporus 30-80, radix Glycyrrhizae 30-80, fructus Piperis Longi 30-80, radix Ginseng Rubra 30-80, radix astragali 30-80, radix Curcumae 30-80, rhizoma Curcumae Longae 30-80, carapax Trionycis 30-80, rhizoma Sparganii 30-80, rhizoma Curcumae 30-80, Olibanum 30-80, Myrrha 30-80, radix Notoginseng 30-80, rhizoma Atractylodis Macrocephalae 30-80, endothelium corneum Gigeriae Galli 30-80, fructus crataegi 30-80, rhizoma Cyperi 30-80, radix bupleuri 30-80, Concha Ostreae 30-80, and Eupolyphaga Seu Steleophaga 30-80.
A method for preparing Chinese medicinal composition comprises the following steps:
s1, weighing groups of medicinal materials, a second group of medicinal materials and a third group of medicinal materials according to the formula of the Chinese medicinal composition;
group of medicinal materials including herba Swertiae Mileensis, cacumen Securinegae Suffruticosae, radix Sophorae Flavescentis, herba Sophorae Alopecuroidis, Polyporus and Glycyrrhrizae radix, the second group of medicinal materials including Atractylodis rhizoma, carapax Trionycis, fructus crataegi and rhizoma Cyperi, and the third group of medicinal materials including Formica Fusca, Ganoderma, fructus Piperis Longi, Ginseng radix Rubri, radix astragali, radix Curcumae, Curcuma rhizome, rhizoma Sparganii, Curcumae rhizoma, Olibanum, Myrrha, Notoginseng radix, Atractylodis rhizoma, endothelium corneum Gigeriae Galli, bupleuri radix, Concha Ostreae and Eupolyphaga Seu Steleophaga;
s2, decocting th medicinal materials in water, and concentrating and drying in the shade to obtain th medicinal preparation;
s3, respectively parching the second group of materials, and mixing to obtain a second preparation;
s4, mixing the th medicament, the second medicament and the third group of medicinal materials, and then sequentially crushing, grinding and sterilizing to obtain the traditional Chinese medicine composition.
In the step S1, genuine medicinal materials are selected and divided into three groups, namely, a decocting group, a stir-frying group and a raw group according to the medicinal principle of each medicinal material, and each group of medicinal materials are washed by clear water and dried for later use;
in step S2, decocting group of medicinal materials in water, and fully extracting effective components from the medicinal materials;
in step S3, the second group of herbs are respectively fried to make the properties of the herbs exert to the maximum;
in step S4, the th drug, the second drug and the third group of drugs are mixed, and then sequentially pulverized, ground and sterilized to prepare the traditional Chinese medicine composition.
, in step S2, the decoction includes times of decoction, the second decoction and the third decoction,
the th decoction is prepared by soaking group of medicinal materials in water for 20-60min according to the weight ratio of 1 (2-4) to water, heating to boil, decocting at 50-100 deg.C until the medicinal liquid is lost (1/3) - (1/2), filtering to obtain th filtrate, and collecting th residue;
the second decoction is to add water in the original weight ratio into th residue, to be decocted at 50-100 ℃ after heating and boiling until the liquid medicine is lost (1/3) - (1/2), to be filtered to obtain a second filtrate, and to collect the second residue;
repeating the second decocting step in the third decocting step to obtain a third filtrate;
mixing the th filtrate, the second filtrate and the third filtrate, decocting at 50-100 deg.C, concentrating, and drying in the shade to obtain th medicinal preparation.
The decocting of the medicinal materials is carried out for three times, water in the original weight ratio is added when the medicinal liquid is lost (1/3) - (1/2) each time, the decocting is carried out continuously under the slow fire at 50-100 ℃, the step is repeated, and finally the filtrates of the three times are mixed and continuously concentrated under the slow fire at 50-100 ℃, so that the method not only can fully extract the effective components in the medicinal materials, but also can ensure that the effective components are enriched at the treatment temperature of 50-100 ℃, and further the th medicament is obtained.
, in step S3, parching the second group of herbs at 50-150 deg.C to light yellow.
The atractylodes macrocephala koidz, the turtle shell, the hawthorn and the monkshood in the second group of medicinal materials are all medicinal materials for stir-frying, and clinical test data show that the four medicinal materials are combined for use after being stir-fried, so that the medicinal properties of the medicinal materials can be exerted to the maximum.
, in step S4, the ground powder is sieved by a 200-mesh sieve with 150 meshes.
The th medicament, the second medicament and the third group of medicinal materials are mixed and crushed and ground through a 150-mesh and 200-mesh sieve, so that the absorption rate of the traditional Chinese medicine composition can be improved.
, in step S4, the sterilization method is to use ultraviolet lamp radiation for 30-60 min.
The ground traditional Chinese medicine composition is subjected to ultraviolet lamp radiation treatment, so that the contact area of ultraviolet light and the traditional Chinese medicine composition can be increased, and the sterilization effect can be achieved in a short time.
application of Chinese medicinal composition in preparing medicine for treating hepatitis.
The Chinese medicinal composition can be used for preparing medicines for treating various hepatitis.
, the medicine is tablet, pill, granule or capsule.
When preparing the hepatitis medicine, the medicine can be prepared into tablets, pills, granules or capsules.
Pharmacological analysis of the traditional Chinese medicine composition:
the black ant has mild nature, and kinds of ant toxin are contained in the body of the black ant, and the toxin is a killer of hepatitis B virus and has the function of controlling and killing the hepatitis B virus.
And (3) green leaf gall: it is also called as meridian tropism, gallbladder meridian tropism, liver meridian, bladder meridian, cold nature and bitter taste, and has the functions of clearing away liver heat, promoting bile flow, clearing away heat and promoting diuresis.
Phyllanthus urinaria L: has effects in suppressing hyperactive liver, clearing away heat, promoting diuresis, and removing toxic substances, and the extract of Phyllanthus urinaria has effects in inhibiting acute hepatitis B virus infection, directly resisting hepatitis B virus, and regulating immune system.
Ganoderma lucidum: has effects of promoting regeneration of human body cells, removing toxic substance, improving immunity, and controlling and repairing canceration of human liver cells.
Matrine and aloperine: has antiviral, liver cell membrane stabilizing, liver cell apoptosis blocking, liver microcirculation improving, liver cell regeneration promoting, and hepatitis B virus replication and immunity inhibiting effects.
And (3) polyporus umbellatus: has diuretic, antitumor and immunity enhancing effects.
Licorice root: the active ingredients of the liquorice are triterpenoid saponin and flavonoid compounds such as glycyrrhizic acid and liquiritin, and have strong pharmacological activity in the aspects of anti-inflammation, antioxidation, anticancer, liver protection and the like.
Repeating the steps of: is slightly cold in nature, and has the effects of clearing away heat and toxic materials, relieving swelling and pain, and cooling liver to arrest convulsion.
Red ginseng: is a cooked product of ginseng, has the functions of invigorating primordial qi, tonifying spleen and lung, promoting the production of body fluid and soothing the nerves, has the characteristics of warmer property, large and powerful fire and strong efficacy, and is better for invigorating primordial qi, restoring yang and rescuing from collapse, and tonifying qi and controlling blood.
Astragalus root: enhancing immunity, promoting urination, and resisting aging.
Turmeric root-tuber: enters heart, lung and liver meridians and is mainly used for hepatitis, cirrhosis and cholecystitis.
Curcumin: has antitumor, antimutagenic, antibacterial, antiviral, antioxidant, and neuroprotective effects.
Turtle shell: has effects of softening and resolving hard mass.
Three shuttles: break blood and move qi, resolve food stagnation and alleviate pain.
Zedoary turmeric: pungent and bitter in flavor and warm in nature, entering liver and spleen meridians; has effects in promoting qi circulation, resolving stagnation, removing blood stasis, and relieving pain.
Frankincense: has obvious pain relieving effect and stronger bacteriostasis effect on various antibiotics.
Myrrh: promoting blood circulation, relieving pain, eliminating swelling, and promoting granulation.
Pseudo-ginseng: stop bleeding, dispel blood and relieve pain.
White atractylodes rhizome: being bitter, warm, pungent and drastic in property, it has the actions of drying dampness, resolving turbidity and alleviating pain.
Endothelium corneum gigeriae galli: sweet in taste and neutral in nature, enters spleen, stomach, small intestine and bladder channels, and has the effects of tonifying spleen, clearing heat, dredging collaterals, regulating qi and the like.
Hawthorn fruit: has effects of reducing blood lipid, lowering blood pressure, tonifying heart, and resisting arrhythmia, and is also effective in invigorating spleen, stimulating appetite, promoting digestion, and promoting blood circulation for removing blood stasis.
Cyperus rotundus: can be used for treating stagnation of qi due to depression of the liver, chest, hypochondrium, abdominal distention and pain, and dyspepsia.
Bupleurum root: slightly cold in nature, bitter and pungent in flavor, entering liver and gallbladder meridians, and has the effects of soothing liver, promoting bile flow, dispelling qi, resolving stagnation and dissipating fire.
Oyster shell: it enters liver, gallbladder and kidney meridians, and liver wind-extinguishing herbs.
B, ground beetle: entering liver meridian, it is indicated for swelling and pain of liver and spleen, lumbar muscle strain and sprain caused by blood stasis.
Compared with the prior art, the traditional Chinese medicine composition for treating hepatitis has the beneficial effects that:
the traditional Chinese medicine composition takes black ants, phyllanthus urinaria, radix curcumae, turtle shells, cyperus rotundus and radix bupleuri as monarch drugs according to a monarch, minister, assistant and guide traditional Chinese medicine compatibility concept, takes black ants as representatives to mainly control and kill hepatitis B viruses, simultaneously takes nutrient components of the black ants as monarch drugs after being dried, absorbed and stored, and synthesizes various vitamins required by human bodies through livers (in the process of absorbing, storing and synthesizing vitamins by the livers, very unfavorable survival and replication environments can be generated for the hepatitis B viruses), the liver cells are surrounded by drugs for controlling and killing the hepatitis B viruses for a long time, and the drugs can repair damaged liver cells and provide sufficient nutrition for the livers to store, so after taking the medicine containing the traditional Chinese medicine composition, the hepatitis B viruses can be automatically discharged from liver , the regeneration and detoxification efficacies of lucid ganoderma lucidum, sophora alopecuroide, red ginseng, turmeric and sanshou as adjuvant drugs, have the regeneration and detoxification efficacies of human body cells, can block the spontaneous hepatic microcirculation of liver cells, can synergistically promote the regeneration of liver cells, inhibit the replication of gallbladder, inhibit the liver, inhibit the replication of gallbladder, transfer of gallbladder, and promote the liver, inhibit the liver, promote the proliferation of chicken liver, promote the proliferation of chicken, promote the liver to restore the liver, promote the liver to promote the regeneration of chicken, promote the liver to promote the regeneration of the liver to promote the regeneration of chicken, promote the liver to promote the regeneration of.
Detailed Description
It is noted that the following detailed description is exemplary and is intended to provide further explanation of the invention at unless otherwise indicated.
It is noted that the terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments according to the present application. As used herein, the singular forms also include the plural forms unless the context clearly dictates otherwise, and further, it is understood that when the terms "comprises" and/or "comprising" are used in this specification, they specify the presence of the stated features, steps, operations, devices, components, and/or combinations thereof.
Hereinafter, embodiments of the present invention will be described in detail. The following examples are only for illustrating the technical solutions of the present invention more clearly, and therefore are only examples, and the protection scope of the present invention is not limited thereby.
The parts of the examples which are not specified in specific conditions were carried out according to conventional conditions or conditions recommended by the manufacturer, and the reagents or equipment used therefor which are not specified by the manufacturer are conventional products which are commercially available, and 1 part in the examples means 1 g.
Example 1
Selecting genuine medicinal materials, respectively washing with clear water and drying in the air, weighing groups of medicinal materials including mile swertia herb 10 parts, phyllanthus urinaria 10 parts, sophora flavescens 10 parts, sophora alopecuroides 10 parts, polyporus umbellatus 10 parts and liquorice 10 parts, adding water according to the proportion of 1:2 to soak for 20min, then heating and boiling, decocting at 50 ℃ until the liquid medicine is lost 1/3, filtering to obtain filtrate, collecting residues, supplementing water in the residues according to the original weight ratio, heating and boiling, decocting at 50 ℃ until the liquid medicine is lost 5, filtering to obtain second filtrate, collecting second residues, repeating the step of decocting for the second time to obtain third filtrate, finally mixing filtrate, second filtrate and third filtrates, decocting and concentrating at 50 ℃ in the shade to obtain medicament, weighing 10 parts of bighead atractylodes rhizome, turtle shell 10 parts, hawthorn 10 parts, monkshood 10 parts, mixing 10 parts of astragalus root and myrrh, grinding 10 parts of astragalus root, 10 parts of curcuma, 10 parts of astragalus root, 10 parts of black sesame, 10 parts of radix curcuma, 10 parts of astragalus root, myrrh, 10 parts of astragalus root, myrrh, 10 parts of astragalus root and 10 parts of ground by using 10-7-element radiation, 10-7-10-7-mesh radiation, 10-three-mesh radiation, 10-mesh radiation, 10-mesh grinding and.
Example 2
Selecting genuine medicinal materials, respectively washing with clear water and drying in the air, weighing groups of medicinal materials of 30 parts of swertia mileensis, 30 parts of phyllanthus urinaria, 30 parts of sophora flavescens, 30 parts of sophora alopecuroides, 30 parts of grifola and 30 parts of liquorice, adding water according to the proportion of 1:4 to soak for 60min, then heating and boiling, decocting at 100 ℃ until the liquid medicine is lost 1/2, filtering to obtain filtrate, collecting residues, supplementing water in the original weight ratio to residues, heating and boiling, decocting at 100 ℃ until the liquid medicine is lost 1/2, filtering to obtain second filtrate, collecting second residues, repeating the step of decocting for the second time to obtain third filtrate, finally mixing filtrate, second filtrate and third filtrates, decocting and concentrating at 100 ℃ in the shade to obtain medicament, weighing 30 parts of atractylodes macrocephala second group of atractylis ovata, 30 parts of hawthorn, 30 parts of aconite, mixing with 30 parts of astragalus membranaceus, 30min, 30 parts of curcuma, 30 parts of astragalus membranaceus, 30 parts of curcuma, 30 parts of radix curcuma, 30 parts of ground by using an ultraviolet radiation, 30-7-membered lamp, 30-year-30-fried traditional Chinese medicine, 30-fried traditional Chinese medicine, ground three groups of ground traditional Chinese medicine after grinding, myrrh and 30-element medicine, 30-trogopteres, 30-trogopterus.
Example 3
Selecting genuine medicinal materials, respectively washing with clear water and drying in the air, weighing groups of medicinal materials including mile swertia herb 80 parts, phyllanthus urinaria 80 parts, sophora flavescens 80 parts, sophora alopecuroides 80 parts, polyporus umbellatus 80 parts and liquorice 80 parts, adding water according to the proportion of 1:4 to soak for 60min, then heating and boiling, decocting at 80 ℃ until the liquid medicine is lost 1/2, filtering to obtain filtrate, collecting residues, supplementing water in the residues according to the original weight ratio, heating and boiling, decocting at 80 ℃ until the liquid medicine is lost 5, filtering to obtain second filtrate, collecting second residues, repeating the step of decocting for the second time to obtain third filtrate, finally mixing filtrate, second filtrate and third filtrates, decocting and concentrating at 80 ℃ in the shade to obtain medicament, weighing 80 parts of bighead atractylodes rhizome, 80 parts of turtle shell, 80 parts of hawthorn, 80 parts of monkshood, respectively turning over to be yellowish at 100 ℃, mixing 80 min, drying in the shade to obtain 80 parts of astragalus root, 80 parts of curcuma rhizome, 80 parts of curcuma zedoary, 80 parts of astragalus root 80, 80 parts of astragalus root of ground into 80, 80 parts of black ginseng, 80 parts of astragalus root 80, myrrh, 80 parts of astragalus root 80, myrrh, 80-mesh traditional Chinese-ground, ground into powder, ground into.
Example 4
Selecting genuine medicinal materials, respectively washing with clear water and drying in the air, weighing 100 parts of swertia mileensis, 100 parts of phyllanthus urinaria, 100 parts of sophora flavescens, 100 parts of sophora alopecuroides, 100 parts of grifola and 100 parts of liquorice, adding water according to the proportion of 1:4 to soak for 60min, heating and boiling, decocting at 100 ℃ until the liquid medicine is lost 1/2, filtering to obtain filtrate, collecting th residue, supplementing water in the original weight ratio to th residue, heating and boiling, decocting at 100 ℃ until the liquid medicine is lost 5, filtering to obtain , collecting second residue, repeating the step of decocting for the second time to obtain third filtrate, finally mixing filtrate, second filtrate and third filtrates, decocting and concentrating at 100 ℃ in the shade to obtain 1/2 medicinal preparation, weighing 100 parts of atractylodes macrocephala, 100 parts of turtle shell, 100 parts of hawthorn, 100 parts of monkshood, mixing 100 parts of astragalus root, 100 parts of curcuma, 100 parts of astragalus root, 100 parts of curcuma longa medicinal material, 100 parts of astragalus root, 100 parts of curcuma zedoary, 100 parts of astragalus root, 100 parts of curcuma aromatica, 100 parts of ground, 100 parts of ground with 100 parts of black ginseng, 100 parts of ground, 100 parts of astragalus root, 100 parts of ground with 100-fried astragalus root, 100-element lamp, 100-mesh lamp, myrrh.
Comparative example
The traditional Chinese medicine for treating chronic hepatitis comprises the following raw materials of 20 parts of artemisia capillaries, 6 parts of subprostrate sophora, 5 parts of polygonum cuspidatum, 6 parts of swertia mileensis, 5 parts of broadleaf holly leaf, 2 parts of rhizoma sparganii, 6 parts of dandelion, 8 parts of radix scrophulariae, 6 parts of gallnut, 10 parts of platycodon grandiflorum, 6 parts of polygonum multiflorum, 2 parts of muskroot-like semiaquilegia root, 6 parts of dark plum fruit, 8 parts of codonopsis pilosula, 5 parts of golden cypress, 9 parts of photinia serrulata leaf and 4 parts of platycladi seed.
The results of treatment courses of 7 days after which the results of treatment were compared with those of the control example 2 in 50 patients with chronic hepatitis shown in Table 1 below.
Table 1 comparison of the therapeutic effects of example 2 and the control
Classes of Chinese herbs | Number of examples | Healing examples | Working examples | Examples of invalidity |
Example 2 | 50 | 46 | 3 | 1 |
Comparative example | 50 | 41 | 6 | 3 |
As can be seen from table 1, the cure rate of example 2 is 92%, the ineffective rate is not 2%, and the cure rate of the control example is 82%, and the ineffective rate is 6%, so that the cure rate of the example in treating chronic hepatitis diseases is higher than that of the control example, and the ineffective rate is lower than that of the control example, therefore, the traditional Chinese medicine composition of the example has a better effect in treating chronic hepatitis diseases than that of the control example, and the higher the glutamic-pyruvic transaminase, glutamic-oxalacetic transaminase, total bilirubin and indirect bilirubin are, the better the treatment effect of the traditional Chinese medicine composition is.
Typical cases are:
case 1: liu Yi, male and 52 years old, this patient got a diagnosis in his hospital of the people in the area of Netherlands in 8 months of 2009 due to symptoms such as abdominal distension, weakness, yellow urine, etc., and it was diagnosed as hepatitis B, which belongs to three positive, glutamic-pyruvic transaminase, glutamic-oxalacetic transaminase, total bilirubin, indirect bilirubin and hepatitis B virus are all higher. The pill of the traditional Chinese medicine composition prepared in the embodiment 1 is taken 2 times a day, 10g of the pill each time, 3 courses of treatment are taken, the big three positive is changed into the small two positive, the glutamic-pyruvic transaminase, the glutamic-oxalacetic transaminase and the total bilirubin are all reduced to the normal range, and the indirect bilirubin and the hepatitis B virus are all reduced to the normal range.
Case 2: zhangzhi, male, 60 years old, the patient was diagnosed with ascites due to cirrhosis in 2008 due to symptoms such as lack of strength, abdominal distension, emaciation, oliguria, etc., the capsule of the traditional Chinese medicine composition prepared in the embodiment 3 was taken 2 times a day at a dose of 10g each time for 3 courses of treatment, and the symptoms such as lack of effusion in abdominal cavity, strength lack of strength, abdominal distension, etc. were almost completely eliminated in B-ultrasonography.
Case 3: plum, male and 58 years old, the patient is diagnosed with hepatosplenomegaly in 2013 due to symptoms such as hypodynamia, nausea, vomiting, continuous abdominal distension, dark complexion and the like, the capsule of the traditional Chinese medicine composition prepared in the embodiment 4 is taken for 3 treatment courses at a dose of 10g each time 2 times a day, the B-ultrasonic examination is matched with liver function examination and blood routine examination, the hepatosplenomegaly symptom disappears, and various indexes such as glutamic-pyruvic transaminase and glutamic-oxalacetic transaminase are normal.
Case 4: wangzhi, female, 55 years old, patients were diagnosed with hepatitis B, glutamic-pyruvic transaminase, glutamic-oxalacetic transaminase, total bilirubin, indirect bilirubin and hepatitis B virus in 2015 due to upper abdominal discomfort, liver pain and hypodynamia, and the pills of the traditional Chinese medicine composition prepared in the embodiment 2 were taken 2 times a day at a dose of 10g each time for 3 courses of treatment, wherein the glutamic-pyruvic transaminase, the glutamic-oxalacetic transaminase and the total bilirubin are all reduced to normal ranges, and other symptoms are basically disappeared.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the invention, and any modifications, equivalents, improvements and the like that fall within the spirit and principle of the present invention are intended to be included therein.
Claims (9)
10-100 parts of black ants, 10-100 parts of swertia mileensis, 10-100 parts of phyllanthus urinaria, 10-100 parts of ganoderma lucidum, 10-100 parts of radix sophorae flavescentis, 10-100 parts of sophora alopecuroides, 10-100 parts of polyporus umbellatus, 10-100 parts of liquorice, 10-100 parts of fructus trichosanthis, 10-100 parts of red ginseng, 10-100 parts of astragalus membranaceus, 10-100 parts of radix curcumae, 10-100 parts of curcuma longa, 10-100 parts of turtle shell, 10-100 parts of sambucus chinensis, 10-100 parts of curcuma zedoary, 10-100 parts of frankincense, 10-100 parts of myrrh, 10-100 parts of pseudo-ginseng, 10-100 parts of bighead atractylodes rhizome, 10-100 parts of chicken gizzard membrane, 10-100 parts of hawthorn, 10-100 parts of cyperus rotundus, 10-100 parts of radix bupleuri, 10-100 parts of oyster and 10-100 parts of eupolyphaga.
2. The traditional Chinese medicine composition according to claim 1, which is characterized by comprising the following raw material components in parts by weight: 30-80 parts of black ants, 30-80 parts of swertia mileensis, 30-80 parts of phyllanthus urinaria, 30-80 parts of lucid ganoderma, 30-80 parts of radix sophorae flavescentis, 30-80 parts of sophora alopecuroides, 30-80 parts of polyporus umbellatus, 30-80 parts of liquorice, 30-80 parts of fructus trichosanthis, 30-80 parts of red ginseng, 30-80 parts of astragalus membranaceus, 30-80 parts of radix curcumae, 30-80 parts of curcuma longa, 30-80 parts of turtle shell, 30-80 parts of rhizoma sarcandrae, 30-80 parts of curcuma zedoary, 30-80 parts of frankincense, 30-80 parts of myrrh, 30-80 parts of pseudo-ginseng, 30-80 parts of bighead atractylodes rhizome, 30-80 parts of endothelium corneum gigeriae galli, 30-80 parts of hawthorn, 30-80 parts of cyperus rotundus, 30-80 parts.
3. The method of preparing the composition of any one of of claims 1-2, comprising the steps of:
s1, weighing groups of medicinal materials, a second group of medicinal materials and a third group of medicinal materials according to the formula of the Chinese medicinal composition;
group of medicinal materials including herba Swertiae Mileensis, cacumen Securinegae Suffruticosae, radix Sophorae Flavescentis, herba Sophorae Alopecuroidis, Polyporus and Glycyrrhrizae radix, the second group of medicinal materials including Atractylodis rhizoma, carapax Trionycis, fructus crataegi and rhizoma Cyperi, and the third group of medicinal materials including Formica Fusca, Ganoderma, fructus Piperis Longi, Ginseng radix Rubri, radix astragali, radix Curcumae, Curcuma rhizome, rhizoma Sparganii, Curcumae rhizoma, Olibanum, Myrrha, Notoginseng radix, Atractylodis rhizoma, endothelium corneum Gigeriae Galli, bupleuri radix, Concha Ostreae and Eupolyphaga Seu Steleophaga;
s2, decocting th medicinal materials in water, and concentrating and drying in the shade to obtain th medicinal preparation;
s3, respectively parching the second group of materials, and mixing to obtain a second preparation;
s4, mixing the th medicament, the second medicament and the third group of medicinal materials, and then sequentially crushing, grinding and sterilizing to obtain the traditional Chinese medicine composition.
4. The preparation method of claim 3, wherein the decoction comprises times of decoction, a second time of decoction and a third time of decoction in the step S2,
the th decoction is prepared by soaking group of medicinal materials in water for 20-60min according to the weight ratio of 1 (2-4) to water, heating to boil, decocting at 50-100 deg.C until the medicinal liquid is lost (1/3) - (1/2), filtering to obtain th filtrate, and collecting th residue;
the second decoction is to add water in the original weight ratio into th residue, to be decocted at 50-100 ℃ after heating and boiling until the liquid medicine is lost (1/3) - (1/2), to be filtered to obtain a second filtrate, and to collect the second residue;
repeating the second decocting step in the third decocting step to obtain a third filtrate;
mixing the th filtrate, the second filtrate and the third filtrate, decocting at 50-100 deg.C, concentrating, and drying in the shade to obtain th medicinal preparation.
5. The preparation method according to claim 3, wherein in step S3, the second group of herbs are respectively stir-fried at 50-150 ℃ until the second group of herbs are slightly yellow.
6. The method as claimed in claim 3, wherein in step S4, the ground material is sieved through a 150-mesh and 200-mesh sieve.
7. The method for preparing a pharmaceutical composition according to claim 3, wherein the sterilization is performed by UV irradiation for 30-60min in step S4.
8. Use of the Chinese medicinal composition of any one of claims 1-7 in the preparation of a medicament for the treatment of hepatitis.
9. Use according to claim 8, wherein the medicament is a tablet, a pill, a granule or a capsule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911185299.1A CN110732012A (en) | 2019-11-27 | 2019-11-27 | A Chinese medicinal composition for treating hepatitis, and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911185299.1A CN110732012A (en) | 2019-11-27 | 2019-11-27 | A Chinese medicinal composition for treating hepatitis, and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110732012A true CN110732012A (en) | 2020-01-31 |
Family
ID=69274000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911185299.1A Pending CN110732012A (en) | 2019-11-27 | 2019-11-27 | A Chinese medicinal composition for treating hepatitis, and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110732012A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
-
2019
- 2019-11-27 CN CN201911185299.1A patent/CN110732012A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
Non-Patent Citations (2)
Title |
---|
朱曾柏: "三七妙用", 《辽宁中医杂志》 * |
钟有添等: "中医药治疗病毒性乙型肝炎研究进展", 《赣南医学院学报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105012452A (en) | New application of clausena lansium leaves | |
CN103977361A (en) | Traditional Chinese medicine for treating ascites caused by cirrhosis and preparation method thereof | |
CN111920938A (en) | Bupleurum root antidote drug composition and preparation method and application thereof | |
CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
CN113521232A (en) | Traditional Chinese medicine composition containing bighead atractylodes rhizome | |
CN104435686A (en) | Use of traditional Chinese medicine preparation in preparation of medicine for treating skin itch and eczema papulosum | |
CN104740521B (en) | Preparation method of Ganfule soft capsule | |
CN107184750B (en) | Medicine for treating chronic glomerulonephritis and nephrotic syndrome and preparation method thereof | |
CN107737195A (en) | A kind of Chinese veterinary medicinal composition for treating swine fever and its preparation method and application | |
CN110732012A (en) | A Chinese medicinal composition for treating hepatitis, and its preparation method | |
CN104740520B (en) | Ganfule soft capsule and preparation method thereof | |
CN103041048A (en) | Traditional Chinese medicine composition for treating animal enteritis and diarrhea and preparation method of same | |
CN101549140B (en) | Traditional Chinese medicine composition for treating AIDS and preparation method thereof | |
CN105267711A (en) | Pharmaceutical preparation for treating vertigo | |
CN101375962B (en) | Formulation for activating blood and freeing collateral vessels and preparation method thereof | |
CN101129748A (en) | Proprietary Chinese medicine for treating cancer of the lungs and method of preparing the same | |
CN1130529A (en) | Aizikangfuning-Chinese patent drug for treating AIDS and preparing process thereof | |
CN103127417A (en) | Drug for curing nasosinusitis and preparation method thereof | |
CN108186874B (en) | A Chinese medicinal composition for treating diabetes | |
CN104825977A (en) | Traditional Chinese medicine composition for treating spleen deficiency food damage type postpartum food damage and preparation method of traditional Chinese medicine composition | |
CN104547945A (en) | Traditional Chinese medicine preparation for treating scrofula and preparation method of traditional Chinese medicine preparation | |
CN105641168A (en) | Medicine for treating viral hepatitis B and viral hepatitis C and preparation method of medicine | |
CN105194296A (en) | Medicine composition for treating heart diseases | |
CN104208620A (en) | Anti-virus preparation and preparation method thereof | |
CN113521226A (en) | Pure traditional Chinese medicine preparation for treating leucoderma and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Tongsheng Inventor after: Wang Suhong Inventor before: Wang Tongsheng |
|
CB03 | Change of inventor or designer information | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200131 |
|
RJ01 | Rejection of invention patent application after publication |